(Q40369356)

19 September 2017

title

A phase II window trial of procarbazine and topotecan in children with high-grade glioma: a report from the children's oncology group (English)

1 reference

19 September 2017

main subject

phase II clinical trial

0 references

1 reference

2

Henry S Friedman

1 reference

19 September 2017

14

Susan M Blaney

1 reference

19 September 2017

5

Roger E McLendon

1 reference

19 September 2017

8

Peter Burger

1 reference

19 September 2017

11

James Rutka

1 reference

19 September 2017

author name string

Murali M Chintagumpala

1

1 reference

19 September 2017

Clinton F Stewart

3

1 reference

19 September 2017

James Kepner

4

1 reference

19 September 2017

Paul L Modrich

6

1 reference

19 September 2017

Charles McCluggage

7

1 reference

19 September 2017

Emi Holmes

9

1 reference

19 September 2017

Stephen Thompson

10

1 reference

19 September 2017

Jeff Michalski

12

1 reference

19 September 2017

Shiao Woo

13

1 reference

19 September 2017

Larry E Kun

15

1 reference

19 September 2017

Marc E Horowitz

16

1 reference

19 September 2017

Pediatric Oncology Group Study

17

1 reference

19 September 2017

publication date

1 April 2006

1 reference

Journal of Neuro-Oncology

19 September 2017

published in

1 reference

19 September 2017

volume

77

1 reference

19 September 2017

issue

2

1 reference

19 September 2017

page(s)

193-198

1 reference

https://scigraph.springernature.com/pub.10.1007/s11060-005-9024-x

19 September 2017

exact match

0 references

cites work

Procarbazine chemotherapy in the treatment of recurrent malignant astrocytomas after radiation and nitrosourea failure

1 reference

Crossref

https://api.crossref.org/works/10.1007%2FS11060-005-9024-X

Changes in O6-methylguanine-DNA methyltransferase expression during immortalization of cloned human fibroblasts

21 January 2018

1 reference

12 December 2020

DNA mismatch repair and O6-alkylguanine-DNA alkyltransferase analysis and response to Temodal in newly diagnosed malignant glioma.

1 reference

12 December 2020

Comparison between BCNU and procarbazine chemotherapy for treatment of gliomas.

1 reference

12 December 2020

Comparisons of carmustine, procarbazine, and high-dose methylprednisolone as additions to surgery and radiotherapy for the treatment of malignant glioma

1 reference

12 December 2020

Activity of 9-dimethylaminomethyl-10-hydroxycamptothecin against pediatric and adult central nervous system tumor xenografts

1 reference

12 December 2020

Results of a phase II upfront window of pharmacokinetically guided topotecan in high-risk medulloblastoma and supratentorial primitive neuroectodermal tumor

1 reference

12 December 2020

O6-alkylguanine-DNA alkyltransferase and sensitivity to procarbazine in human brain-tumor xenografts

1 reference

12 December 2020

Phase II testing of melphalan in children with newly diagnosed rhabdomyosarcoma: a model for anticancer drug development

1 reference

12 December 2020

Relationship between topotecan systemic exposure and tumor response in human neuroblastoma xenografts

1 reference

12 December 2020

Immunohistochemical detection of the DNA repair enzyme O6-methylguanine-DNA methyltransferase in formalin-fixed, paraffin-embedded astrocytomas.

1 reference

12 December 2020

The effectiveness of chemotherapy for treatment of high grade astrocytoma in children: results of a randomized trial. A report from the Childrens Cancer Study Group

1 reference

12 December 2020

Confidence intervals following group sequential tests.

1 reference

12 December 2020

Superiority of post-radiotherapy adjuvant chemotherapy with CCNU, procarbazine, and vincristine (PCV) over BCNU for anaplastic gliomas: NCOG 6G61 final report

1 reference

12 December 2020

Methylator resistance mediated by mismatch repair deficiency in a glioblastoma multiforme xenograft.

1 reference

12 December 2020

Randomized phase III trial in childhood high-grade astrocytoma comparing vincristine, lomustine, and prednisone with the eight-drugs-in-1-day regimen. Childrens Cancer Group.

1 reference

12 December 2020

Phase I study of topotecan for pediatric patients with malignant solid tumors

1 reference

12 December 2020

Designs for group sequential phase II clinical trials.

1 reference

12 December 2020

Pediatric phase I trial and pharmacokinetic study of topotecan administered as a 24-hour continuous infusion

1 reference

12 December 2020

Phase II window studies: 10 years of experience and counting

1 reference

12 December 2020

A comparison of human O6-methylguanine-DNA methyltransferase promoter activity in Mer+ and Mer- cells

1 reference

12 December 2020

Phase I trial of O6-benzylguanine for patients undergoing surgery for malignant glioma.

1 reference

12 December 2020

Procarbazine hydrochloride in the treatment of brain tumors. Phase 2 study

1 reference

12 December 2020

Effect of 5-azacytidine on expression of the human DNA repair enzyme O6-methylguanine-DNA methyltransferase

1 reference

12 December 2020

10.1007/S11060-005-9024-X

Identifiers

DOI

1 reference

Dimensions Publication ID

19 September 2017

1039279998

0 references

1 reference